by editor | Jan 8, 2016 | Clinicians, Participants, Researchers
Journal paper describes rationale and design of the new ASPREE hearing sub-study Loss of hearing can have a profound effect on a person’s independence and quality of life. Up to two-thirds of people over the age of 70 years will experience hearing loss...
by editor | Nov 30, 2015 | Clinicians, Participants, Researchers
Late last month saw the launch of an aspirin study called ADD-Aspirin to investigate whether aspirin can be used to prevent or delay the recurrence of a cancer. People living in India, Ireland and the UK who have had, or are undergoing early treatment for cancer in...
by editor | Oct 6, 2015 | Clinicians, Participants, Researchers
Researchers await verification of aspirin and cancer survival announcement A report that aspirin doubled the life expectancy of patients with gastrointestinal cancer should be viewed with caution until there is proof to substantiate the claim, said Australian...
by editor | Mar 25, 2015 | Clinicians, Participants, Researchers
A recent report that an individual’s genetic make-up could determine whether aspirin had a positive or negative effect on colorectal (bowel) cancer, is inconclusive said a leading cancer researcher and oncologist, Professor Peter Gibbs. Above: Prof Peter Gibbs is a...
by editor | Dec 2, 2014 | Clinicians, Participants, Researchers
A recap on aspirin and primary prevention aspirin trials Professor Mark Nelson, Chief Investigator to the ASPREE trial in Tasmania, talks to Norman Swan about aspirin and primary prevention Above: Practicing GP, Prof. Mark Nelson, a Chief Investigator to...
Recent Comments